Melt Pain Away

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Melt Pain Away
Generic name: CAPSAICIN
Manufacturer: Proximity Capital Partners LLC dba Asutra
Product type: HUMAN OTC DRUG
SPL set ID: a95a11d7-a2ae-6654-e053-2a95a90a802c
SPL ID: 37da3909-1e23-f5d9-e063-6294a90a8f48
Version: 3
Effective date: 2025-06-18
Source export date: 2026-10-12
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:44:42

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Melt Pain Away	openfda.brand_name
generic name		CAPSAICIN	openfda.generic_name
manufacturer name		Proximity Capital Partners LLC dba Asutra	openfda.manufacturer_name
ndc	package	72683-003-02	openfda.package_ndc
ndc	package	72683-003-01	openfda.package_ndc
ndc	product	72683-003	openfda.product_ndc
ndc11	package	72683000302	derived:openfda.package_ndc
ndc11	package	72683000301	derived:openfda.package_ndc
rxcui		198555	openfda.rxcui
spl id		37da3909-1e23-f5d9-e063-6294a90a8f48	id
spl set id		a95a11d7-a2ae-6654-e053-2a95a90a802c	set_id
unii		S07O44R1ZM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Use only as directed. For external use only. When using this product: avoid contact with eyes do not apply to wounds or damaged skin do not bandage tightly Stop use and ask doctor if: condition worsens symptoms persist for more than 7 days, or clear up and reoccur again with a few days redness is present irritation develops. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children . If accidentally ingested, get medical help or contact Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.